UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
17.05% 17.17% 17.82% 18.31%

+8 more TTM periods

Piotroski F-Score
4 5 5 6
ROA
10.98% 10.42% 10.64% 10.40%
ROIC
10.29% 10.15% 10.44% 10.65%
Return on Tangible Assets
30.96% 30.43% 33.28% 34.73%
Average Days of Receivables
67.82 61.48 53.42 53.10
Free Cash Flow per Share
7.95 9.01 10.26 11.34
Free Cash Flow
61.50 69.55 79.03 87.47
Capital Expenditures
(10.08) (11.75) (12.87) (12.02)
Other line items
Cash ROIC
10.20% 11.40% 13.31% 15.01%
Accounts Receivable Turnover
6.19 6.10 6.78 6.70
Accounts Payable Turnover
16.24 15.01 17.81 15.35
Inventory Turnover
4.88 4.75 4.96 4.89
Average Days of Payables
26.64 23.79 20.50 25.14
Days of Inventory on Hand
80.89 78.64 73.32 73.56
Tax Rate
(0.18) (0.18) (0.17) (0.18)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
13.27% 13.10% 12.85% 12.56%
Share Based Compensation of Revenue
1.63% 1.54% 1.47% 1.42%
Interest Coverage
12.40 10.60 9.42 8.27
Operating CF/Net income
0.99 1.18 1.35 1.48
Depreciation/Fixed assets
0.26 0.25 0.24 0.24
Capex/Depreciation
(0.51) (0.60) (0.67) (0.64)
Revenue per Share
81.61 78.86 78.23 77.54
Operating CF per Share
9.25 10.53 11.93 12.90
Capex per Share
(1.30) (1.52) (1.67) (1.56)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates